Macrogol Laxatives Market By Drug Name (Movicol; Casenlax; VistaPrep; CosmoCol; Molaxole; Endofalk; Glycoprep; Forlax; Laxido; MiraLAX and Other Macrogols), By Disease (Inflammatory Bowel Diseases (IBD); Irritable Bowel Syndrome (IBS); Drug Induced Constipation (DIC); and Other Diseases), By Age Group (Baby Boomers and Older; Generation X; Millennials; Generation Z; and Generation Alpha) - Growth, Future Prospects and Competitive Analysis, 2020 – 2027
Constipation is a very common condition across the world both in adults and children and it impacts the physical and emotional well-being considerably. In adults, the frequency of constipation differs from 2.5% to 79% whereas; in children it is about 0.7% to 29.6%. It has been found that constipation becomes more frequent after the age of 60 years. In addition, people belonging to lower income groups have considerably more frequent constipation than wealthier ones. Constipation occurs less frequently in people with more years of parental education and more frequently in people with high body mass index (BMI) and immobility or less physical activity. Further risk factors for constipation are low-fibre food intake, living in a highly densely populated community, constipation in the family and experiencing anxiety, stressful life events and depression.
Macrogol Laxatives Market has proven to be a safe and effective treatment for constipation for both children and elderly patients. On account of higher water content, the volume of the faecal mass increases which triggers forceful bowel movements via distension of the colonic wall. The increased water content softens the faeces and eases its motion. A relatively low dose of Macrogol helps in improving stool frequency and consistency in patients with chronic constipation. Macrogol continues to be effective in the long term without the need to increase the dosage over time. Although Macrogol is not associated with severe side effects, it may cause diarrhea and bloating Macrogol does not alter the normal structure of the surface of the bowel.
The report titled “Global Macrogol Laxatives Market- Growth, Future Prospects and Competitive Analysis, 2020 – 2027” provides in-depth analysis into the global macrogol laxatives market in addition to market size and estimates for the period from 2017 to 2027. The research study provides strategic insights on various market segments based on drug name, disease, age group and cross-sectional analysis for different geographic regions. The report offers comparative analysis of various segments for the years 2019 and 2027.
In order to help decision makers, the report covers competitive profiling of the leading manufacturers of macrogol laxatives, competitive landscape and key market developments. Some of the major players included in the report are Norgine B.V., RECORDATI S.p.A., Tillotts Pharma AG, Stirling Anglian Pharmaceuticals, Meda AS, Dr. Falk Pharma GmbH, Fresenius Kabi Australia Pty Limited, Ipsen Group, Galen Limited, and Bayer Health Care LLC.
Other detailed analysis covered in the report includes:
- Current and future market trends to point out attractive investment areas within the macrogol laxatives industry
- Market drivers, market restraints, and their impact on the market estimations
- In-depth competitive analysis
- 2-year historic market size data (2017 – 2018)
Overall, the research study provides a comprehensive view of the global macrogol laxatives market, offering market size and estimates for the forecast period from 2020 to 2027, considering the above mentioned dynamics.
Chapter 1 Preface 14
1.1 Report Description 14
1.1.1 Purpose of the Report 14
1.1.2 Target Audience 14
1.1.3 USP and Key Offerings 14
1.2 Research Scope 15
1.3 Research Methodology 16
1.3.1 Phase I – Secondary Research 16
1.3.2 Phase II – Primary Research 17
1.3.3 Phase III – Expert Panel Review 17
1.3.4 Assumptions 18
1.3.5 Approach Adopted 18
Chapter 2 Executive Summary 19
2.1 Market Snapshot: Global Macrogol Market 19
2.2 Global Macrogol Market, By Drug Name 20
2.3 Global Macrogol Market, By Disease 21
2.4 Global Macrogol Market, By Age Group 22
2.5 Global Macrogol Market, By Geography 23
Chapter 3 Market Dynamics 24
3.1 Market Overview 24
3.1.1 Global Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y) 25
3.2 Market Drivers 25
3.2.1 Benefits of Macrogol over other osmotic laxatives 25
3.2.2 Sedentary lifestyle resulting in higher instances of constipation 26
3.3 Challenges 26
3.3.1 Approval from various regional regulatory agencies 26
3.4 Opportunity: 27
3.4.1 Accessing other international markets 27
3.5 Impact Analysis of Drivers and Restraints 28
Chapter 4 Global Macrogol Market, By Drug Name 29
4.1 Overview 29
4.1.1 Global Macrogol Market Value Share, By Drug Name, 2019 & 2027 (% Value) 29
4.2 Movicol 30
4.2.1 Global Movicol Market Value, 2017 – 2027, (US$ Mn) 30
4.3 Casenlax 31
4.3.1 Global Casenlax Market Value, 2017 – 2027, (US$ Mn) 31
4.4 VistaPrep 32
4.4.1 Global VistaPrep Market Value, 2017 – 2027, (US$ Mn) 32
4.5 CosmoCol 33
4.5.1 Global CosmoCol Market Value, 2017 – 2027, (US$ Mn) 33
4.6 Molaxole 34
4.6.1 Global Molaxole Market Value, 2017 – 2027, (US$ Mn) 34
4.7 Endofalk 35
4.7.1 Global Endofalk Market Value, 2017 – 2027, (US$ Mn) 35
4.8 Glycoprep 36
4.8.1 Global Glycoprep Market Value, 2017 – 2027, (US$ Mn) 36
4.9 Forlax 37
4.9.1 Global Forlax Market Value, 2017 – 2027, (US$ Mn) 37
4.10 Laxido 38
4.10.1 Global Laxido Market Value, 2017 – 2027, (US$ Mn) 38
4.11 MiraLAX 39
4.11.1 Global MiraLAX Market Value, 2017 – 2027, (US$ Mn) 39
4.12 Other Macrogols 40
4.12.1 Global Other Macrogols Market Value, 2017 – 2027, (US$ Mn) 40
Chapter 5 Global Macrogol Market, By Disease 41
5.1 Overview 41
5.1.1 Global Macrogol Market Value Share, By Disease, 2019 & 2027 (% Value) 41
5.2 Inflammatory Bowel Diseases (IBD) 42
5.2.1 Global Macrogol Market Value for Inflammatory Bowel Diseases (IBD), 2017 – 2027, (US$ Mn) 42
5.3 Irritable Bowel Syndrome (IBS) 43
5.3.1 Global Macrogol Market Value for Irritable Bowel Syndrome (IBS), 2017 – 2027, (US$ Mn) 43
5.4 Drug Induced Constipation (DIC) 44
5.4.1 Global Macrogol Market Value for Drug Induced Constipation (DIC), 2017 – 2027, (US$ Mn) 44
5.5 Other Diseases 45
5.5.1 Global Macrogol Market Value for Other Diseases, 2017 – 2027, (US$ Mn) 45
Chapter 6 Global Macrogol Market, By Age Group 46
6.1 Overview 46
6.1.1 Global Macrogol Market Value Share, By Age Group, 2019 & 2027 (% Value) 46
6.2 Baby Boomers and Older 47
6.2.1 Global Macrogol Market Value for Baby Boomers and Older, 2017 – 2027, (US$ Mn) 47
6.3 Generation X 48
6.3.1 Global Macrogol Market Value for Generation X, 2017 – 2027, (US$ Mn) 48
6.4 Millennials 49
6.4.1 Global Macrogol Market Value for Millennials, 2017 – 2027, (US$ Mn) 49
6.5 Generation Z 50
6.5.1 Global Macrogol Market Value for Generation Z, 2017 – 2027, (US$ Mn) 50
6.6 Generation Alpha 51
6.6.1 Global Macrogol Market Value for Generation Alpha, 2017 – 2027, (US$ Mn) 51
Chapter 7 North America Macrogol Market Analysis 52
7.1 Overview 52
7.1.1 North America Macrogol Market Value, 2017 – 2027, (US$ Mn) 52
7.2 North America Macrogol Market Analysis, By Disease, 2017 – 2027 (US$ Mn) 53
7.3 North America Macrogol Market Analysis, By Age Group, 2017 – 2027 (US$ Mn) 53
7.4 North America Macrogol Market Analysis, By Country, 2017 – 2027 (US$ Mn) 54
Chapter 8 Europe Macrogol Market Analysis 55
8.1 Overview 55
8.1.1 Europe Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y %) 55
8.2 Europe Macrogol Market Analysis, By Disease, 2017 – 2027 (US$ Mn) 56
8.3 Europe Macrogol Market Analysis, By Age Group, 2017 – 2027 (US$ Mn) 56
8.4 Europe Macrogol Market Analysis, By Country, 2017 – 2027 (US$ Mn) 57
Chapter 9 Asia Pacific Macrogol Market Analysis 58
9.1 Overview 58
9.1.1 Asia Pacific Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y %) 58
9.2 Asia Pacific Macrogol Market Analysis, By Disease, 2017 – 2027 (US$ Mn) 59
9.3 Asia Pacific Macrogol Market Analysis, By Age Group, 2017 – 2027 (US$ Mn) 59
9.4 Asia Pacific Macrogol Market Analysis, By Country, 2017 – 2027 (US$ Mn) 60
Chapter 10 Latin America Macrogol Market Analysis 61
10.1 Overview 61
10.1.1 Latin America Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y %) 61
10.2 Latin America Macrogol Market Analysis, By Disease, 2017 – 2027 (US$ Mn) 62
10.3 Latin America Macrogol Market Analysis, By Age Group, 2017 – 2027 (US$ Mn) 62
10.4 Latin America Macrogol Market Analysis, By Country, 2017 – 2027 (US$ Mn) 63
Chapter 11 Middle East and Africa (MEA) Macrogol Market Analysis 64
11.1 Overview 64
11.1.1 MEA Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y %) 64
11.2 MEA Macrogol Market Analysis, By Disease, 2017 – 2027 (US$ Mn) 65
11.3 MEA Macrogol Market Analysis, By Age Group, 2017 – 2027 (US$ Mn) 65
11.4 MEA Macrogol Market Analysis, By Country, 2017 – 2027 (US$ Mn) 66
Chapter 12 Company Profiles 67
12.1 Norgine B.V. 67
12.1.1 Norgine B.V. : Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 67
12.2 RECORDATI S.p.A. 69
12.2.1 RECORDATI S.p.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 69
12.3 Tillotts Pharma AG 71
12.3.1 Tillotts Pharma AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 71
12.4 Stirling Anglian Pharmaceuticals 73
12.4.1 Stirling Anglian Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 73
12.5 Meda AS 75
12.5.1 Meda AS: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 75
12.6 Dr. Falk Pharma GmbH 77
12.6.1 Dr. Falk Pharma GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 77
12.7 Fresenius Kabi Australia Pty Limited 79
12.7.1 Fresenius Kabi Australia Pty Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 79
12.8 Ipsen Group 81
12.8.1 Ipsen Group: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 81
12.9 Galen Limited 83
12.9.1 Galen Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 83
12.10 Bayer Health Care LLC 85
12.10.1 Bayer Health Care LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 85
TABLE 1 Market Snapshot: Global Macrogol Market 19
TABLE 2 Impact Indicators 28
TABLE 3 Impact Analysis of Drivers and Restraints 28
TABLE 4 North America Macrogol Market Value, By Disease, 2017 – 2027 (US$ Mn) 53
TABLE 5 North America Macrogol Market Value, By Age Group, 2017 – 2027 (US$ Mn) 53
TABLE 6 North America Macrogol Market Value, By Country, 2017 – 2027 (US$ Mn) 54
TABLE 7 Europe Macrogol Market Value, By Disease, 2017 – 2027 (US$ Mn) 56
TABLE 8 Europe Macrogol Market Value, By Age Group, 2017 – 2027 (US$ Mn) 56
TABLE 9 Europe Macrogol Market Value, By Country, 2017 – 2027 (US$ Mn) 57
TABLE 10 Asia Pacific Macrogol Market Value, By Disease, 2017 – 2027 (US$ Mn) 59
TABLE 11 Asia Pacific Macrogol Market Value, By Age Group, 2017 – 2027 (US$ Mn) 59
TABLE 12 Asia Pacific Macrogol Market Value, By Country, 2017 – 2027 (US$ Mn) 60
TABLE 13 Latin America Macrogol Market Value, By Disease, 2017 – 2027 (US$ Mn) 62
TABLE 14 Latin America Macrogol Market Value, By Age Group, 2017 – 2027 (US$ Mn) 62
TABLE 15 Latin America Macrogol Market Value, By Country, 2017 – 2027 (US$ Mn) 63
TABLE 16 MEA Macrogol Market Value, By Disease, 2017 – 2027 (US$ Mn) 65
TABLE 17 MEA Macrogol Market Value, By Age Group, 2017 – 2027 (US$ Mn) 65
TABLE 18 MEA Macrogol Market Value, By Country, 2017 – 2027 (US$ Mn) 66
TABLE 19 Norgine B.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 67
TABLE 20 RECORDATI S.p.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 69
TABLE 21 Tillotts Pharma AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 71
TABLE 22 Stirling Anglian Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 73
TABLE 23 Meda AS: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 75
TABLE 24 Dr. Falk Pharma GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 77
TABLE 25 Fresenius Kabi Australia Pty Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 79
TABLE 26 Ipsen Group: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 81
TABLE 27 Galen Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 83
TABLE 28 Bayer Health Care LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments) 85
FIG. 1 Global Macrogol Market: Research Methodology 16
FIG. 2 Top-Down and Bottom Up Approach 18
FIG. 3 Global Macrogol Market, By Drug Name, 2019 (US$ Mn) 20
FIG. 4 Global Macrogol Market, By Disease, 2019 (US$ Mn) 21
FIG. 5 Global Macrogol Market, By Age Group, 2019 (US$ Mn) 22
FIG. 6 Global Macrogol Market, By Geography, 2019 (US$ Mn) 23
FIG. 7 Global Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y) 25
FIG. 8 Global Macrogol Market Value Share, By Drug Name, 2019 & 2027 (% Value) 29
FIG. 9 Global Movicol Market Value, 2017 – 2027, (US$ Mn) 30
FIG. 10 Global Casenlax Market Value, 2017 – 2027, (US$ Mn) 31
FIG. 11 Global VistaPrep Market Value, 2017 – 2027, (US$ Mn) 32
FIG. 12 Global CosmoCol Market Value, 2017 – 2027, (US$ Mn) 33
FIG. 13 Global Molaxole Market Value, 2017 – 2027, (US$ Mn) 34
FIG. 14 Global Endofalk Market Value, 2017 – 2027, (US$ Mn) 35
FIG. 15 Global Glycoprep Market Value, 2017 – 2027, (US$ Mn) 36
FIG. 16 Global Forlax Market Value, 2017 – 2027, (US$ Mn) 37
FIG. 17 Global Laxido Market Value, 2017 – 2027, (US$ Mn) 38
FIG. 18 Global MiraLAX Market Value, 2017 – 2027, (US$ Mn) 39
FIG. 19 Global Other Macrogols Market Value, 2017 – 2027, (US$ Mn) 40
FIG. 20 Global Macrogol Market Value Share, By Disease, 2019 & 2027 (% Value) 41
FIG. 21 Global Macrogol Market Value for Inflammatory Bowel Diseases (IBD), 2017 – 2027, (US$ Mn) 42
FIG. 22 Global Macrogol Market Value for Irritable Bowel Syndrome (IBS), 2017 – 2027, (US$ Mn) 43
FIG. 23 Global Macrogol Market Value for Drug Induced Constipation (DIC), 2017 – 2027, (US$ Mn) 44
FIG. 24 Global Macrogol Market Value for Other Diseases, 2017 – 2027, (US$ Mn) 45
FIG. 25 Global Macrogol Market Value Share, By Age Group, 2019 & 2027 (% Value) 46
FIG. 26 Global Macrogol Market Value for Baby Boomers and Older, 2017 – 2027, (US$ Mn) 47
FIG. 27 Global Macrogol Market Value for Generation X, 2017 – 2027, (US$ Mn) 48
FIG. 28 Global Macrogol Market Value for Millennials, 2017 – 2027, (US$ Mn) 49
FIG. 29 Global Macrogol Market Value for Generation Z, 2017 – 2027, (US$ Mn) 50
FIG. 30 Global Macrogol Market Value for Generation Alpha, 2017 – 2027, (US$ Mn) 51
FIG. 31 North America Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y %) 52
FIG. 32 Europe Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y %) 55
FIG. 33 Asia Pacific Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y %) 58
FIG. 34 Latin America Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y %) 61
FIG. 35 MEA Macrogol Market Value and Growth, 2017 – 2027, (US$ Mn) (Y-o-Y %) 64
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)